Business Wire

PA-COHESIVE-COMP/OXPLUS

5.10.2021 22:03:10 CEST | Business Wire | Press release

Share
The Cohesive Companies Expand in Transportation Infrastructure Globally with Acquisition of OXplus and through Executive Succession

The Cohesive Companies, a wholly-owned but independently operated digital integrator business unit of Bentley Systems, Incorporated (Nasdaq:BSY), the infrastructure engineering software company, today announced its acquisition of OXplus, the leading rail asset management specialist headquartered in Veghel, Netherlands. The acquisition coincides with the appointment of Dr. Mark Bew MBE as CEO of The Cohesive Companies, succeeding Noah Eckhouse, who has retired after 17 years of exemplary service within Bentley Systems capped by the successful convergence, from multiple predecessor organizations, of The Cohesive Companies in 2020. OXplus becomes the sixth brand to enter The Cohesive Companies fold in support of its mission to deliver the strongest social, economic, and environmental outcomes for infrastructure clients and their constituents.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211005005250/en/

OXplus supports rail owners, operators, and maintainers, and rolling stock manufacturers around the globe with digital tools and solutions that give them a deep insight into the performance of their assets. It builds smart systems, and delivers standout client experiences, that use IoT data to effectively predict when repair or intervention is needed, that prevent downtime, that reduce operational costs, and that enable efficient scheduling of assets. The acquisition of OXplus, founded in 2010, will accelerate The Cohesive Companies’ expansion of its Enterprise Asset Management presence within Europe and elsewhere. For instance, OXplus has recently supported the prestigious Riyadh Metro project, the largest single-phase metro project underway globally, and is also supporting Siemens Mobility to efficiently execute the maintenance of Riyadh Metro’s new train fleet.

Bew joined Bentley Systems and The Cohesive Companies with its 2020 acquisition of the UK-based built-environment consultancy PCSG, providing digital advisory services and solutions to world-leading owners and operators in the transportation sector. Representative clients and projects include HS2, Europe’s largest infrastructure project, in developing a digital twin of the entire rail system; Highways England (National Highways), operator of the UK strategic road network; and Heathrow Airport Ltd. Prior to his co-leadership of PCSG, Bew held information and business system leadership roles with Costain and URS-Scott Wilson. Based in London, Bew also chaired the UK government’s BIM Task Group, which led the work to embed digital techniques and processes within major UK public sector infrastructure programs.

In a further appointment, George Church has been named COO of The Cohesive Companies. Based in Boston, USA, Church brings a depth of knowledge and expertise gained through 27 years at Bentley Systems, including as senior vice president of its professional services business.

Mark Bew said, “We are delighted to welcome the OXplus team to enhance The Cohesive Companies’ balance across geographies and sectors. Our collective success and learning curves in delivering projects while working fully virtually throughout the pandemic has proven our growth strategy in globally bringing together and further attracting world-class talent resources. I take the helm from Noah Eckhouse enthusiastic about our unique strengths as a full lifecycle digital integrator, delivering transformational outcomes across the built and natural environment, independent of our clients’ investment choices among technology vendors. It is particularly meaningful to me that OXplus’ proficiencies in rail and transport operations and service optimization now helps us be able to fulfill the vision, expressed through the UK public sector’s digital twin aspirations, for improved social benefits from infrastructure.”

OXplus CEO Henri Snijders said, “We are excited that OXplus is joining The Cohesive Companies to strengthen our position as a leading digital consultancy in the railways and transportation sectors. I would like to thank all the team at OXplus for their work and dedication in making this milestone possible.”

Richard Van Dongen, OXplus CCO, added, “Advancements in going digital are driving improvements on major railways projects leading toward the breakthrough advantages of infrastructure and of rolling stock digital twins. We know that together, we can deliver even more operational value for the transportation sector.”

##

About The Cohesive Companies

The Cohesive Companies form a wholly owned but independently operated business unit of Bentley Systems (Nasdaq:BSY, the infrastructure engineering software company www.bentley.com ). The Cohesive Companies provide advisory, systems integration, and technology strategies and services to help owner-operators advance their BIM, enterprise asset management (EAM), asset lifecycle information (ALIM), and asset performance modeling environments. Our uniquely comprehensive expertise in infrastructure digital twins spans from development platforms to operational systems, from cloud to mobile, from asset delivery to customer service optimization, and beyond resourceful technology implementation to change management and business process redesign. The Cohesive Companies have coalesced and globally multiplied the reach and capabilities of Cohesive Solutions, Cohesive Asset Performance, SRO Solutions, PCSG, Ontracks Consulting, and OXplus. www.cohesivecompanies.com

© 2021 Bentley Systems, Incorporated. Bentley, Cohesive Solutions, Cohesive Asset Performance, Ontracks, OXplus, PCSG, SRO Solutions, and The Cohesive Companies are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye